Louisville, CO, United States of America

George N Cox

USPTO Granted Patents = 58 


 

Average Co-Inventor Count = 1.6

ph-index = 20

Forward Citations = 3,677(Granted Patents)

Forward Citations (Not Self Cited) = 3,230(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
58 patents (USPTO):

Sure, here is the article about inventor George N Cox:

Title: The Pioneering Work of George N Cox in Radioprotective Therapies

Introduction:

George N Cox, a prolific inventor based in Louisville, Colorado, has made significant contributions to the field of radioprotective therapies. With an impressive portfolio of 57 patents, Cox's innovative research and inventions have focused on developing treatments to mitigate the adverse effects of radiation exposure.

Latest Patents:

Among his latest patents, Cox has pioneered groundbreaking methods and compositions for hematopoietic growth factor proteins and analogs, as well as angiotensin converting enzyme inhibitors for the treatment of radiation exposure. These inventions aim to address both the acute and long-term effects of radiation exposure, offering new hope for individuals who have been or will be exposed to radiation.

Career Highlights:

Throughout his career, George N Cox has collaborated with leading biotechnology companies to bring his inventions to life. Notably, he has worked with Bolder Biotechnology, Inc. and Sangamo Biosciences, Inc., where his innovative research has been instrumental in advancing radioprotective therapies.

Collaborations:

In his research endeavors, George N Cox has collaborated closely with esteemed coworkers, including Casey Christopher Case and Stephen P Eisenberg. Their collective efforts have yielded groundbreaking discoveries in the field of radioprotective therapies, further solidifying Cox's reputation as a trailblazer in the industry.

Conclusion:

In conclusion, George N Cox's pioneering work in developing radioprotective therapies has not only advanced the field of medical science but also offered new possibilities for individuals at risk of radiation exposure. With his continued dedication to innovation, Cox's contributions are shaping the future of radioprotection and underscoring the importance of research in improving health outcomes for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…